These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 5849534)

  • 21. [Acetylsalicylic acid matrices for use in stomatology].
    Rabisková M
    Ceska Slov Farm; 1996 May; 45(3):123-4. PubMed ID: 8696691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-Aminopyridine tablets; a method for the preparation. In-vitro and in-vivo studies.
    Uges DR; Versluis A; Ket JM; Wesseling H
    Pharm Acta Helv; 1982; 57(4):122-8. PubMed ID: 7089018
    [No Abstract]   [Full Text] [Related]  

  • 23. The preparation and properties of tablets containing indomethacin and polyethylene glycol 6000.
    Ford JL
    Pharm Acta Helv; 1983; 58(4):101-8. PubMed ID: 6867041
    [No Abstract]   [Full Text] [Related]  

  • 24. [Paracetamol pharmacokinetics in the blood plasma of sexually immature rabbits with the use of the new Paravit preparation].
    Shapovalova VO
    Fiziol Zh (1994); 1995; 41(5-6):57-60. PubMed ID: 9026394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of directly compressible vehicles for the preparation of vitamin B1 tablets.
    El Sabbagh HM; El Shaboury MH
    Pharmazie; 1984 Apr; 39(4):237-9. PubMed ID: 6739527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dynamics of the liberation of drugs from tablets. II. Liberation of ascorbic acid].
    Pasich J; Lipiarz D
    Acta Pharm Hung; 1982 Jan; 52(1):10-4. PubMed ID: 7058687
    [No Abstract]   [Full Text] [Related]  

  • 27. [Potentiometric determination of ascorbic acid in Vitamin C containing chinacisal tablets and powders].
    Pethö G
    Acta Pharm Hung; 1982 Sep; 52(5):228-32. PubMed ID: 7148478
    [No Abstract]   [Full Text] [Related]  

  • 28. [Investigation on the formula of Fuyankang dispersed tablets].
    Tao HM; Wang LS; Heng DY; Xu MC
    Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(22):1742-4. PubMed ID: 16468368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preparation and in vitro release of ginkgo biloba extract sustained-release tablets].
    Cui Q; Zhu Y; Cui J
    Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(15):1910-3. PubMed ID: 19894532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ascorbic acid in diet supplements: loss in the manufacturing process and storage.
    Giménez R; Cabrera C; Olalla M; Ruiz MD; López MC
    Int J Food Sci Nutr; 2002 Nov; 53(6):509-18. PubMed ID: 12590746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and characterization of a copper based Indian traditional drug: tamra bhasma.
    Wadekar MP; Rode CV; Bendale YN; Patil KR; Prabhune AA
    J Pharm Biomed Anal; 2005 Oct; 39(5):951-5. PubMed ID: 16095857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on tablets. IX. Behavior of auxiliary substances and their mixtures in making tablets].
    Malý J
    Cesk Farm; 1965 Oct; 14(8):401-6. PubMed ID: 5853281
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the polymorphism of barbiturates in powders and tablets. 6: Properties and behaviour of a spray-dried barbital preparation].
    Matzkó-Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1982 Aug; 37(8):562-5. PubMed ID: 7146063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on foods fortified with L-ascorbic acid derivatives. I. Preparation and properties of L-ascorbic phosphate (author's transl)].
    Tao GQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Jan; 15(1):30-3. PubMed ID: 7307800
    [No Abstract]   [Full Text] [Related]  

  • 35. [Preparation of a levodopa/carbidopa solution in ascorbic acid (citridopa) and chromatographic and electrochemical assessment of its stability over 24 hours].
    López Lozano JJ; Moreno Cano R
    Neurologia; 1995 Apr; 10(4):155-8. PubMed ID: 7786540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The correlation between the results of keeping vitamin C tablets under accelerated storage test and under normal conditions].
    Nerlo H; Wieluńska Z
    Ann Univ Mariae Curie Sklodowska Med; 1966; 21():275-80. PubMed ID: 5996260
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on tablets. XV. Holocellulose and technical cellulose as substances promoting the disintegration of tablets].
    Malý J; Chalabala M; Heliová M; Necesaný V
    Cesk Farm; 1967 May; 16(4):194-7. PubMed ID: 6080493
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of ascorbic acid supplementation on periodontal tissue ultrastructure in subjects with progressive periodontitis.
    Aurer-Kozelj J; Kralj-Klobucar N; Buzina R; Bacic M
    Int J Vitam Nutr Res; 1982; 52(3):333-41. PubMed ID: 6757168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The influence of some additives on the breakage resistance of tablets].
    Kedvessy G; Mucsi E
    Pharm Zentralhalle Dtschl; 1965; 104(5):309-14. PubMed ID: 5866179
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.